Back to All Events

2026 Best of ASCO® Maine


  • Holiday Inn Portland by the Bay 88 Spring St. Portland, ME 04101 (map)

In-Person Access Only | 7.50 CE/CME Credits & MOC Points

Please read: All programs remain free. Registrations will require a credit card as a cancellation hold. A fee of $99 will only be incurred in the event of a no-show or cancellation within 5 days without written confirmation to the Total Health Program Team. Industry representatives—defined as any individual who is employed by, contracted with, owns, or represents a drug, device, diagnostic, or other healthcare-related commercial entity, regardless of clinical credentials or licensure—are not permitted to attend Total Health events as general attendees. Members of industry must contact exhibits@totalhealthoncology.com

Total Health's 2026 Best of ASCO® Maine Conference is an officially licensed Best of ASCO® meeting. This Post ASCO® Annual Meeting review showcases abstracts from highly rated presentations, allowing attendees to engage with the latest research and strategies in oncology education. This accredited meeting will be hosted as an in-person conference only with on-demand access for registered attendees.

 

Program Chairs:
Eleni Nackos, MD (New England Cancer Specialists)
Christian Thomas, MD (New England Cancer Specialists)

Conference Agenda

Saturday, August 1, 2026

8:00 AM
Coffee and Exhibits

8:30 AM
Program Chair Welcome

8:40 AM
Colorectal Cancer
Matthew Dugan, MD | New England Cancer Specialists

9:10 AM
Non-Colorectal Cancer

Mary Linton Peters, MD | Massachusetts General Hospital

9:40 AM
Breakfast and Exhibits

9:55 AM
Non-CME Breakfast - Exelixis - A Combination Treatment for Patients with Advanced Renal Cell Carcinoma

Rahul Ravilla, MD | New York Oncology Hematology, Albany Medical Center

10:40 AM
Prostate Cancer

Christian Thomas, MD (Program Chair) | New England Cancer Specialists

11:10 AM
Non-Prostate Cancer‍ ‍
Atish Choudhury, MD | Dana-Farber Cancer Institute

11:40 AM
Lunch and Exhibits

11:55 AM
Non-CME Lunch - Natera - Key insights from ASCO 2026 and the evolving role of ctDNA

Avani Mangoli | Natera

12:40 PM
Housekeeping and Survey

12:50 PM
Leukemia
Brandon J. Aubrey, MBBS, PhD | Massachusetts General Hospital

1:20 PM
Lymphoma
Joseph Tuscano, MD | UC Davis

1:50 PM
Multiple Myeloma
Hamza Hashmi, MD | Memorial Sloan Kettering Cancer Center

2:20 PM
Melanoma‍ ‍
‍ ‍
James Smithy, MD | Memorial Sloan Kettering Cancer Center

2:50 PM
ADJOURN

Sunday, August 2, 2026

7:30 AM
Coffee and Exhibits

8:15 AM
Program Chair Welcome

8:20 AM
Small Cell Lung Cancer
Millie Das, MD | Stanford University

8:50 AM
Non-Small Cell Lung Cancer

Julia Rotow, MD | Dana-Farber Cancer Institute

9:20 AM
The Emerging Role of PD-1 × VEGF Bispecific Antibodies in NSCLC

Julia Rotow, MD | Dana-Farber Cancer Institute

9:40 AM
Breakfast and Exhibits

9:55 AM
Non-CME Breakfast - Regeneron - Bringing the Data to Life: Learnings from Clinical Trials to Clinical Practice on a Treatment Option for Advanced NSCLC*

Carl Henningson, MD | Regional Cancer Care Associates

10:40 AM
Head and Neck Cancer

Lova Sun, MD | Penn Medicine

11:10 AM
Sarcomas and GIST

Priscilla Merriam, MD | Dana-Farber Cancer Institute

11:40 AM
Lunch and Exhibits

11:55 AM
Non-CME Lunch - Pfizer Breast - Learn About a Treatment Option for Patients With HR+/HER2+ mBC

Reshma Mahtani, DO | Baptist Health South Florida

12:40 PM
Survivorship
Elizabeth Dennis, MD | New England Cancer Specialists

1:10 PM

Early-Stage Breast Cancer
Eleni Nackos, MD | New England Cancer Specialists

1:40 PM
Metastatic Breast Cancer
Reshma Mahtani, DO | Baptist Health South Florida

2:10 PM
ADJOURN

Agenda Subject To Change. All times are EST.

 
 
Previous
Previous
July 25

2026 Best of ASCO® Indianapolis

Next
Next
August 8

2026 Best of ASCO® Boston